You Do Bio

Ahram Biosystems

Ahram Biosystems – Innovative ultra-fast mobile PCR system

Brings Portable Innovation to The Biotechnology Market

Ahram Biosystems, Incorporated stands at the forefront of pioneering life science instruments and has brought forth an innovative and compact solution for the biotechnology industry.

The company’s groundbreaking and rapid Palm PCR™ mobile system caters to the rapidly-evolving molecular diagnostics sector. The establishment, originating in 2001, is based in Seoul, South Korea, with a branch office situated in San Jose, California, USA.

You can also call/text Pete on +45 25 57 38 76

Ahram Biosystems Product

Instruction for use

Using Palm PCR™ Mobile COVID 19 Lab Version 1.0

See this video for more information on how to use Palm PCR™ Mobile COVID 19 Lab Version 1.0

About Ahram Biosystems

Leading Innovator of New Life Science Tools

Ahram Biosystems, Inc. is a biotechnology company that specializes in research and development of portable high-speed PCR devices and cell-based assay systems. With a focus on innovation, Ahram Biosystems offers cutting-edge products and services for life science and pharmaceutical research, as well as healthcare applications.

Since its establishment in 2001, Ahram Biosystems has been at the forefront of PCR amplification and cell-based assays, holding numerous patents in these areas. The company is headquartered in Seoul, Korea, with a business office in Silicon Valley, CA, USA.

About You Do Bio

Hi, my name is Peter Roberts.

After completing my PhD and working in product development and technical support in several life science companies, I founded You Do Bio in Denmark in 2008. With 22 years of experience providing solutions to scientists, I’ve seen how great laboratory technology leads to groundbreaking research, improved clinical outcomes, and faster data collection.

Peter Roberts, founder of You Do Bio

Scroll to Top
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept